Biotech Most Volatile: CytRx Corporation (NASDAQ:CYTR), Merrimack Pharmaceuticals (NASDAQ:MACK), CEL-SCI Corporation (NYSEMKT:CVM), IGI Laboratories (NYSEMKT:IG)

CytRx Corporation (NASDAQ:CYTR) on Mar. 5 reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -4.14% in last session and finished the day at $5.10. Traded volume was 3,687,994 million shares in the last session and the average volume of the … Continue reading Biotech Most Volatile: CytRx Corporation (NASDAQ:CYTR), Merrimack Pharmaceuticals (NASDAQ:MACK), CEL-SCI Corporation (NYSEMKT:CVM), IGI Laboratories (NYSEMKT:IG)

Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at $7.85. Traded volume was 6,155,092 million shares in the last … Continue reading Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

On Jan 22, Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that Birgit M. Schoeberl, Ph.D. has been named the new head of its Discovery division. Ulrik B. Nielsen, Ph.D. will be stepping down as the head of the Discovery division and has been elected to serve on Merrimack’s Board of Directors. Anthony J. Sinskey, Sc.D. will also be resigning from the Board of Directors and will continue … Continue reading Investors Should Watch: Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK), American Airlines Group Inc. (NASDAQ:AAL), General Communication Inc. (NASDAQ:GNCMA), BioCryst Pharmaceuticals (NASDAQ:BCRX), OceanFirst Financial (NASDAQ:OCFC)